We are live on ! Find out more
CTNM

Contineum Therapeutics
CTNM

62 hedge funds and large institutions have $206M invested in Contineum Therapeutics in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

11,500% more call options, than puts

Call options by funds: $232K | Put options by funds: $2K

271% more capital invested

Capital invested by funds: $55.4M → $206M (+$150M)

8.42% more ownership

Funds ownership: 72.53% → 80.95% (+8.4%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

11% less funds holding

Funds holding: 70 → 62 (-8)

36% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 22

Holders
62
Holders Change
-8
Holders Change %
-11.43%
% of All Funds
0.81%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
18
Reduced
18
Closed
22
Calls
$232K
Puts
$2K
Net Calls
+$230K
Net Calls Change
+$230K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$17.1M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$7.67M
3
Millennium Management
Millennium Management
New York
+$4.14M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.78M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.48M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$1.89M
2
SVCM
Saturn V Capital Management
Texas
-$1.27M
3
SSA
Schonfeld Strategic Advisors
New York
-$1.17M
4
ACM
ADAR1 Capital Management
Texas
-$716K
5
Squarepoint
Squarepoint
New York
-$615K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$913K -$1.89M -234,830 -75%
UBS Group
27
UBS Group
Switzerland
$805K +$490K +60,839 +794%
State Street
28
State Street
Massachusetts
$734K +$270K +33,528 +116%
SWA
29
Strategies Wealth Advisors
Michigan
$588K – – –
Northern Trust
30
Northern Trust
Illinois
$575K +$192K +23,794 +95%
BCM
31
Bridgeway Capital Management
Texas
$489K +$180K +22,380 +117%
Renaissance Technologies
32
Renaissance Technologies
New York
$484K +$216K +26,796 +186%
RC
33
RBF Capital
California
$470K – – –
Two Sigma Investments
34
Two Sigma Investments
New York
$446K -$186K -23,020 -38%
Goldman Sachs
35
Goldman Sachs
New York
$354K -$248K -30,787 -51%
TI
36
Trexquant Investment
Connecticut
$344K +$236K +29,310 New
IFG
37
Independent Financial Group
California
$317K – – –
Acadian Asset Management
38
Acadian Asset Management
Massachusetts
$308K +$170K +21,070 +390%
BEAM
39
Baker Ellis Asset Management
Washington
$229K +$157K +19,500 New
SSA
40
Schonfeld Strategic Advisors
New York
$217K -$1.17M -145,628 -89%
Squarepoint
41
Squarepoint
New York
$154K -$615K -76,328 -85%
B
42
Bailard
California
$145K +$99.6K +12,350 New
Mariner
43
Mariner
Kansas
$122K +$84K +10,420 New
Bank of America
44
Bank of America
North Carolina
$85K +$48.6K +6,030 +500%
Barclays
45
Barclays
United Kingdom
$76.1K +$38.2K +4,744 +274%
Wells Fargo
46
Wells Fargo
California
$63K -$17.6K -2,184 -29%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$33K -$3.31K -411 -13%
FDCDDQ
48
Federation des caisses Desjardins du Quebec
Quebec, Canada
$30.1K – – –
PAS
49
Point72 Asia (Singapore)
Singapore
$21.6K -$24.3K -3,010 -62%
TRCT
50
Tower Research Capital (TRC)
New York
$19.7K -$46.6K -5,780 -78%
1
2
3 4

CTNM Hedge Fund Activity: Q3 2025 in Review

62 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Contineum Therapeutics (CTNM) for Q3 2025, worth a combined $206M — up 271% from $55.4M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of CTNM and 14 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 18 added.

The largest buyer was RA Capital Management, opening a new position worth an estimated $17.1M. The largest seller was Baker Bros. Advisors, cutting an estimated $1.89M.

  • 62 institutional investors held Contineum Therapeutics (CTNM) as of Q3 2025, down from 70 in Q2 2025.
  • Funds reported $206M of Contineum Therapeutics stock for Q3 2025, up 271% quarter-over-quarter.
  • 14 funds opened new Contineum Therapeutics positions in Q3 2025 and 22 closed out, a net change of -8 holders.
  • The largest Contineum Therapeutics buyer in Q3 2025 was RA Capital Management, an estimated $17.1M added.
  • The largest Contineum Therapeutics seller in Q3 2025 was Baker Bros. Advisors, an estimated $1.89M sold.

Based on aggregated 13F filings for Q3 2025.